Blommer Chocolate Co. has entered a commercial partnership with Israeli-based DouxMatok to produce and sell a portfolio of chocolate products with less sugar, made possible by enhancing the perception of sweetness.
DouxMatok offers Incredo sugar, which allows formulators to reduce sugar in their products without compromising on taste, texture, or sweetness.
The initial product that the companies would offer is a chocolate-flavored chip with 50 percent less sugar, fewer calories, and more fiber than traditional full-sugar chocolate chips.
The chip will be available to Blommer customers in North America.
The partnership intends to offer new products in confectionery, baking, and dairy.
Ari Melamud, CEO of DouxMatok, explained that Incredo sugar is cane sugar that is structured differently and delivered to the taste receptors more efficiently.
Melamud added that promoting delicious taste and enhanced nutrition while simultaneously improving the health and well-being of consumers are the milestones in leadership in the sugar reduction space that would catapult the industry into the next phase of the food revolution.


Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
India Budget 2026: Modi Government Eyes Reforms Amid Global Uncertainty and Fiscal Pressures
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
Oil Prices Surge Toward Biggest Monthly Gains in Years Amid Middle East Tensions
Japan Election Poll Signals Landslide Win for Sanae Takaichi, Raising Fiscal Policy Concerns
China Home Prices Rise in January as Government Signals Stronger Support for Property Market
Starmer’s China Visit Highlights Western Balancing Act Amid U.S.-China Rivalry
South Korea Exports Surge in January on AI Chip Demand, Marking Fastest Growth in 4.5 Years
SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure
Neuralink Expands Brain Implant Trials with 12 Global Patients
Indonesia Stocks Face Fragile Sentiment After MSCI Warning and Market Rout
Why Trump’s new pick for Fed chair hit gold and silver markets – for good reasons 



